AbCellera Biologics (ABCL)
(Real Time Quote from BATS)
$3.82 USD
-0.03 (-0.78%)
Updated May 24, 2024 12:36 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.16 | -0.96% |
Earnings Summary
For their last quarter, AbCellera Biologics (ABCL) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 12.50%. Look out for ABCL's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 45.45%.
Earnings History
Price & Consensus
Zacks News for ABCL
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ABCL: What are Zacks experts saying now?
Zacks Private Portfolio Services